Lung cancer patients' own immune cells may shrink tumors in new trial
NCT ID NCT07560111
First seen May 15, 2026 · Last updated Jun 12, 2026 · Updated 4 times
Summary
This study tests a treatment made from a patient's own tumor-fighting immune cells (TILs) to see if it can shrink non-small cell lung cancer tumors. About 28 adults aged 18-70 with specific genetic types of lung cancer will receive their own lab-grown cells. The goal is to measure tumor shrinkage and how long it stays controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.